IMRIS launches research initiative

Canadian intraoperative MRI developer IMRIS of Winnipeg, Manitoba, has launched a five-year research initiative that will focus on the development and marketing of MR-guided radiation therapy and interventional procedures.

In collaboration with the University Health Network (UHN) of Toronto, IMRIS will research and test image-guided radiation therapy at UHN's Princess Margaret Hospital with its 3-tesla MR. Planned applications include the integration of IMRIS' technology with external-beam radiation therapy, MR-guided biopsies, and brachytherapy of the prostate, IMRIS said.

Related Reading

IMRIS signs Yale, January 13, 2009

IMRIS takes first Australian order, January 7, 2009

IMRIS nets FDA OK for 3T MRI, December 19, 2008

IMRIS names Rice to U.S. sales post, May 30, 2008

IMRIS signs UVA, May 14, 2008

Copyright © 2009

Page 1 of 57
Next Page